Effects of intensified antihypertensive treatment in diabetic nephropathy: Mortality and morbidity results of a prospective controlled 10-year study

Journal of Hypertension

Volumn 17, Issue 10, 1999, Pages 1497-1503

  Trocha, Anna K ^a   Schmidtke, Claudia ^a   Didjurgeit, Ulrike ^a   Mühlhauser, Ingrid ^a   Bender, Ralf ^a   Berger, Michael ^a   Sawicki, Peter T ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Amputations; Diabetes care; Diabetic nephropathy; Hypertension teaching and treatment programme; Mortality; Retinopathy; Type 1 (insulin dependent) diabetes

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INSULIN;

ADULT; AMPUTATION; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLINDNESS; BLOOD PRESSURE REGULATION; CAUSE OF DEATH; CLINICAL TRIAL; CONSULTATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HEART DISEASE; HEMODIALYSIS; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; RISK; SURVIVAL RATE;

EID: 0032737308     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917100-00019     Document Type: Article

References (31)

1. WHO. Diabetes care and research in Europe. The St Vincente Declaration (ICP/CLR 034). Geneva: World Health Organization; 1989.
2. DCCT Research Group. The effect of intensive treatment of diabetes on the development of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med 1993; 329:977-986.
3. Mogensen CE. The kidney and hypertension in diabetes mellitus. 4th edn. Boston: Kluwer Academic Publishers; 1998.
4. American Diabetes Association. Diabetic retinopathy. Diabetes Care 1998; 21:157-159.
5. Levin ME. Preventing amputations in the patient with diabetes. Diabetes Care 1995; 18:1383-1394.
6. Sawicki PT, Mühlhauser I, Didjurgeit U, Baumgartner A, Bender R, Berger M. Intensified antihypertensive therapy is associated with improved survival in type 1 diabetic patients with nephropathy. J Hypertens 1995; 13:933-938.
7. Mühlhauser I, Bruckner I, Berger M, Cheta D, Jörgens V, Ionescu-Tigoviste C, et al. Evaluation of an intensified insulin treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. Diabetologia 1987; 30:681-690.
8. Mühlhauser I, Sawicki PT, Didjurgeit U, Jörgens V, Berger M. Uncontrolled hypertension in type 1 diabetes: assessment of patients' desires about treatment and improvement of blood pressure control by a structured treatment and teaching programme. Diabetic Med 1988; 5:693-698.
9. Sawicki PT, Didjurgeit U, Mühlhauser I, Heinemann I, Berger M. Near-normotension and near-normoglycaemia in blind Type 1 diabetic patients with overt diabetic nephropathy. J Diabet Complicat 1990; 4: 179-183.
10. Sampson MJ, Drury PL. Accurate estimation of glomerular filtration rate in diabetic nephropathy from age, body weight, and serum creatinine. Diabetes Care 1992; 15:609-612.
11. Maroni B, Steinman TI, Witch WE. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 1985; 27:56-65.
12. Internationale Klassifikation der Krankheiten. ICD-9 revision. 2nd edn. Cologne: Kohlhammer; 1993.
13. Cox DR. Regression models and life tables [with discussion]. JR Statist Soc B 1972; 34:187-220.
14. Hosmer DW, Lemeshow, S. Applied logistic regression. New York: Wiley; 1989.
15. SAS. SAS Technical Report P-217. SAS/STAT software: the PHREG procedure, version 6. Gary, North Carolina: SAS Institute Inc.; 1991.
16. SAS. SAS procedures guide for personal computers, version 6. Cary, North Carolina: SAS Institute Inc.; 1985.
17. SAS. SAS/STAT guide for personal computers, version 6. Cary, North Carolina: SAS Institute Inc.; 1987.
18. SAS. SAS Technical Report P-200. SAS/STAT software: CALIS and LOGISTIC procedures, version 6.04. Cary, North Carolina: SAS Institute Inc.; 1990.
19. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. New Engl J Med 1993; 329:1456-1462.
20. Chaturvedi N, Sjolie AK, Stephenson JM, Adrahamian H, Keipes M, Castellarin A, et al. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. Lancet 1998; 351:28-31.
21. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317:703-713.
22. UK Prospective Diabetes Study Group. Eficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 1998; 317:713-720.
23. Sawicki PT. Do ACE inhibitors offer specific benefits in the antihypertensive treatment of diabetic patients? Diabetologia 1998; 41:598-602.
24. Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Deckert T. Coronary heart disease in young Type 1 (insulin-dependent) diabetic patients with and without nephropathy: incidence and risk factors. Diabetologia 1987; 30:144-148.
25. Tuomilehto J, Borch-Johnsen K, Molarius A, Rastenyte D, Sarti C, Reunanen A. Incidence of cardiovascular disease in Type 1 (insulin dependent) diabetic subjects with and without diabetic nephropathy in Finland. Diabetologia 1998; 41:784-790.
26. Nesto RW, Phillips RT. Asymptomatic myocardial ischemia in diabetic patients. Am J Med 1986; 80 (suppl C):40-47.
27. Earle KA, Mishra M, Morocutti A, Barnes D, Stephens E, Chambers J, et al. Microalbuminuria as a marker of silent myocardial ischaemia in IDDM patients. Diabetologra 1996; 39:854-856.
28. Yudkin JS. How can we best prolong life? The benefits of coronary risk factor reduction in non-diabetic and diabetic subjects. BMJ 1993; 306: 1313-1318.
29. Sawicki PT, Berger M. Pharmacological treatment of diabetic patients with cardiovascular complications. J Intern Med 1998; 243:181-189.
30. Rossing P, Hougaard P, Borch-Johnsen K, Parving HH. Predictors of mortality in insulin dependent diabetes: 10 years observational follow-up study. BMJ 1996; 313:779-784.
31. Bergström J, Alvestrand A, Bucht H. Gutierrez A. Progression of chronic renal failure in man is retarded with more frequent clinical follow-ups and better blood pressure control. Clin Nephrol 1986; 25:1-6.